Waters stock
Price history
+20.48% over the period1 year: from $377.98 (November 17, 2025) to $455.39 (November 16, 2026), +20.48%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | $455.39 |
| October 30, 2026 | $462.72 |
| September 30, 2026 | $439.39 |
| August 31, 2026 | $414.63 |
| July 31, 2026 | $377.31 |
| June 30, 2026 | $375.04 |
| May 29, 2026 | $383.57 |
| April 30, 2026 | $309.23 |
| March 31, 2026 | $297.80 |
| February 27, 2026 | $319.38 |
| January 30, 2026 | $370.72 |
| December 31, 2025 | $379.83 |
| November 28, 2025 | $403.42 |
| November 17, 2025 | $377.98 |
At a glance
The company
Provide analytical workflow solutions including liquid chromatography, mass spectrometry systems, and thermal analysis instruments for pharmaceutical, industrial and research applications
Latest results
Quarter to September 30, 2026 · EPS $4.10 (estimate $4.00)
TickerLandia's take on Waters
- Pricier than usual relative to earnings: P/E on the latest fiscal year 42 vs a median of 30 over its last 9 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 193 vs 36 (+428%) in a group of 10.
- Strong point: Market momentum (81/100 in its group). Weak point: Profitability (31/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−5.78% from the 52-week high
Analysts · 24 analysts
Average target$503.29+10.52% vs. price
Buy 18 · Hold 5 · Sell 1 · Buy
TickerLandia Fingerprint: Waters
Compared with similar companies: very strong momentum.
Financials and price compared with 27 companies in the diagnostics & research industry, worldwide. Momentum and risk compared with 883 North American stocks.
Pricehigh76
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 192.6 94 Forward P/E 27.8 78 EV/EBITDA 28.5 82 Price/book 2.96 29 Price/sales 16.1 98 Profitabilitylow31
How much it earns on revenue and capital.
Metric Value Position in group ROE 1.1% 13 Gross margin 55.4% 54 Operating margin 16.0% 46 Net margin 1.8% 20 ROA 3.9% 24 Earnings stabilityhigh70
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.7% 80 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 61 Growthaverage48
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +2.12% 43 Earnings growth (year over year) −67.00% 2 Revenue growth (year over year) +120.90% 98 Financial strengthhigh71
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 1.89 65 Interest coverage 12.8 67 Net debt/EBITDAcounts in reverse: lower means more financial strength 0.87 74 Debt/equitycounts in reverse: lower means more financial strength 0.36 76 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumvery strong81
How the stock has moved compared with the market.
Metric Value Position in group 1-year return +21.34% 63 Relative strength (3 months) +14.80% 84 Distance from 200-day average +23.33% 90 Relative strength (6 months) +35.28% 89 Riskaverage50
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 31.3% 55 Volatility (60 days) 27.0% 30 Beta (1 year) 0.97 63
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Waters is pricier than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Waters's P/E today is 42.3, above the median of its last 9 fiscal years (29.6; between 21.0 and 35.3 from 2016 to 2025). Waters's P/E (trailing 12 months): 192.6, +428% against the median of a group of 10 similar companies (36.5).
Compared with 10 similar companies
| Metric | Waters | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 192.6 | High | |
| Forward P/E | 27.8 | Middle | |
| Operating margin | 16.0% | Middle | |
| ROE | 1.1% | Low | |
| Debt/equity | 0.36 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Waters. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$1.65B
Latest quarter · Q2 2026
Net income
-$136M
Latest quarter · Q2 2026
Quarterly net margin
-8.3%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $90.45B
- P/E
- 192.6
- EPS
- $2.39
- Volume
- 521.84K
- Daily trading
- €408.85M
- Dividend yield
- 0.00%
- Last ex-dividend on November 26, 1996
How Waters is changing
All resultsRevenue grew 6.0% a year on average over the last 5 years
Operating margin fell from 29.4% to 25.4%
Free cash flow equal to 83% of net income
Returns
Waters returns
$1,000 invested in Waters 5 years ago, on November 16, 2021, would be worth $1,305 today: +30.48% in total, +5.47% per year. This is the price return only: dividends are excluded.
| Period | Waters | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +4.22% | −3.12% | $1,042 |
| 6 months | +38.32% | +2.07% | $1,383 |
| Year to date | +19.89% | +10.46% | $1,199 |
| 1 year | +20.48% | +13.33% | $1,205 |
| 3 years | +71.07% | +67.73% | $1,711 |
| 5 years | +30.48% | +60.86% | $1,305 |
| 10 years | +223.66% | +247.35% | $3,237 |
Over the last 6 months it has done better than 75% of the stocks in the Healthcare sector.
Price only, without dividends. Calculate your investment
The chart in detail
Waters: technical analysis
Waters is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 5.1% below its all-time closing high ($480.07, October 29, 2026).
- Trend
- Upward
- RSI (14 sessions)
- 50
- Between 30 and 70
- vs 200-session average
- +21.88%
Support and resistance
Price areas where Waters has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price$455.39
- Support$423.91−6.91%2 touches, last on October 8, 2026
- Support$413.61−9.18%3 touches, last on September 24, 2026
- Support$398.55−12.48%2 touches, last on August 21, 2026
Volatility and risk
Over the last year it has moved roughly in line with the S&P 500.
- Beta (1 year) vs S&P 500
- 0.97
- Volatility (60 sessions, annualised)
- 27.0%
- Largest fall in the last year
- −31.32%
In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Waters: seasonality
Average monthly price change over 31 years
Over the last 31 years, the strongest month for Waters has been January: +3.80% on average, positive in 18 years out of 31. The weakest has been March: −0.56% on average, positive in 17 years out of 31. November, the current month, has been positive in 21 years out of 30 (+2.88% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +3.80% | +5.11% | 18 of 31 |
| February | +0.67% | +1.26% | 18 of 31 |
| March | −0.56% | +0.85% | 17 of 31 |
| April | +2.80% | +2.72% | 19 of 31 |
| May | +2.23% | +1.46% | 19 of 31 |
| June | +1.68% | +2.25% | 20 of 31 |
| July | +1.64% | +0.61% | 16 of 31 |
| August | +1.62% | +0.63% | 19 of 31 |
| September | +1.98% | +1.82% | 17 of 31 |
| October | +0.37% | +2.81% | 16 of 31 |
| November | +2.88% | +3.17% | 21 of 30 |
| December | +2.51% | +1.09% | 18 of 31 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Waters and its competitors
Sales are spread across the Americas, Europe and Asia. The US accounts for 30.5% of revenue, Europe for 30.4%, other Asian markets for 19.0%, China for 13.8% and other Americas markets for 6.2%. Waters Corporation designs, manufactures, sells and services liquid chromatography and mass spectrometry systems, along with chromatography columns and other consumables. Its Waters and TA segments also offer thermal analysis, rheometry and calorimetry instruments, plus software that works with its own and other manufacturers' instruments.
- Headquarters
- Milford, United States
- Employees
- 15,000
- Founded
- 1958
- Chief executive
- Udit Batra
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| WatersWAT | $90.45B | 16.0% | 192.6 | +38.32% |
| IDEXX LaboratoriesIDXX | $55.48B | 32.5% | 47.0 | +33.81% |
| DanaherDHR | $163.94B | 22.0% | 38.6 | +43.33% |
| Agilent TechnologiesA | $49.04B | 24.5% | 34.3 | +55.11% |
| NateraNTRA | $46.27B | -8.5% | — | +56.81% |
| IQVIA HoldingsIQV | $43.36B | 13.9% | 32.0 | +56.42% |
Same industry or related industries, similar size. Compare Waters with its competitors · Full profile
